Intervention: Docetaxel, Anthracycline (Doxorubicin or Epirubicin), Cyclophosphamide
Found 63 matching trials
Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
PHASE3
The purpose of this study is to compare the pathological complete response ...
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer
PHASE2
This multicenter, non-randomized, open-label, phase 2 study is designed to ...
Status
Completed
Location
University of South Alabama; Mitchell Cancer Institute
Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction
PHASE3
The main clinical goal of NAC is to down-stage the primary tumor for BCS,ye...
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
PHASE3
This randomized, double-blind, placebo-controlled, two-arm study will asses...